Cargando…
Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells
Most anticancer treatments only induce the death of ordinary cancer cells, while cancer stem cells (CSCs) in the quiescent phase of cell division are difficult to kill, which eventually leads to cancer drug resistance, metastasis, and relapse. Therefore, CSCs are also important in targeted cancer th...
Autores principales: | Chen, Li, Luo, Jinlan, Zhang, Jingyuan, Wang, Siyuan, Sun, Yang, Liu, Qinying, Cheng, Cui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380749/ https://www.ncbi.nlm.nih.gov/pubmed/37511335 http://dx.doi.org/10.3390/ijms241411575 |
Ejemplares similares
-
Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
por: Zou, Seyin, et al.
Publicado: (2012) -
Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang, Dandan, et al.
Publicado: (2017) -
Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
por: Haghiralsadat, Fateme, et al.
Publicado: (2018) -
Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021) -
Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023)